High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients
Authors
Keywords
Vulvar squamous cell carcinoma, Wee1, Treatment, Targeted therapy, Biomarkers
Journal
BMC CANCER
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-06-15
DOI
10.1186/1471-2407-13-288
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expressional Difference of RHEB, HDAC1, and WEE1 Proteins in the Stromal Tumors of the Breast and Their Significance in Tumorigenesis
- (2012) Minseob Eom et al. Korean Journal of Pathology
- Cyclin-Dependent Kinase Suppression by WEE1 Kinase Protects the Genome through Control of Replication Initiation and Nucleotide Consumption
- (2012) H. Beck et al. MOLECULAR AND CELLULAR BIOLOGY
- High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy
- (2012) Gry Irene Magnussen et al. PLoS One
- WEE1 inhibition sensitizes osteosarcoma to radiotherapy
- (2011) Jantine PosthumaDeBoer et al. BMC CANCER
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation
- (2011) Kurtis D. Davies et al. CANCER BIOLOGY & THERAPY
- MK-1775, a Potent Wee1 Inhibitor, Synergizes with Gemcitabine to Achieve Tumor Regressions, Selectively in p53-Deficient Pancreatic Cancer Xenografts
- (2011) N. V. Rajeshkumar et al. CLINICAL CANCER RESEARCH
- Role of TP53 Mutations in Vulvar Carcinomas
- (2011) Matthias Choschzick et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Wee1 controls genomic stability during replication by regulating the Mus81-Eme1 endonuclease
- (2011) Raquel Domínguez-Kelly et al. JOURNAL OF CELL BIOLOGY
- MK1775, a Selective Wee1 Inhibitor, Shows Single-Agent Antitumor Activity against Sarcoma Cells
- (2011) J. M. Kreahling et al. MOLECULAR CANCER THERAPEUTICS
- Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication
- (2011) C. S. Sorensen et al. NUCLEIC ACIDS RESEARCH
- The Prognostic Value of 14-3-3 Isoforms in Vulvar Squamous Cell Carcinoma Cases: 14-3-3β and ε Are Independent Prognostic Factors for These Tumors
- (2011) Zhihui Wang et al. PLoS One
- Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes
- (2010) Zhihui Wang et al. BMC CANCER
- The G2 DNA damage checkpoint: Could this ancient regulator be the Achilles heel of cancer?
- (2010) Karen Kuntz et al. CANCER BIOLOGY & THERAPY
- In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper against Mitotic Catastrophe in Glioblastoma
- (2010) Shahryar E. Mir et al. CANCER CELL
- Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase
- (2010) Halfdan Beck et al. JOURNAL OF CELL BIOLOGY
- γH2AX: a sensitive molecular marker of DNA damage and repair
- (2010) L-J Mah et al. LEUKEMIA
- Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
- (2009) Sergio Pecorelli INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Integrated Functional, Gene Expression and Genomic Analysis for the Identification of Cancer Targets
- (2009) Elizabeth Iorns et al. PLoS One
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started